Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

68 -- Acquisition of Therapeutic Products for Treatment of Inhalational Anthrax Disease for the Strategic National Stockpile

Solicitation Number: Reference-Number-2004-N-01385
Agency: Department of Health and Human Services
Office: Office of the Secretary
Location: Acquisitions Management, Contracts, & Grants (AMCG)
  • Print
:
Reference-Number-2004-N-01385
:
Award
:
September 27, 2005
:
HHSO100200500006C & HHSO100200500007C
:
1,797,372 & 422,880
:
CLINS 1 & 2 Only
:
The DHHS, ORDC, has awarded 2 contracts off RFP 200-N-01385, Anthrax Therapeutics.
1. Human Genome Sciences
14200 Shady Grove Road
Rockville, Maryland 20850
Contract# HHSO100200500006C
$1,797,372

2. Cangene Corporation
104 Chancellor Matheson Road
Winnipeg, Manitoba
Canada, R3T5Y3
Contract# HHSO100200500007C
$422,880
:
Added: August 18, 2004 Modified: October 3, 2005Track Changes
No Description Provided
:
Department of Health and Human Services, Office of the Secretary, Office of Public Health Emergency Preparedness, Office of Research and Development Coordination 200 Independence Avenue, SW Room 636G, Washington, DC, 20201
:
Lorenzo Falgiano, Contracting Officer, Phone 770-448-2629, Fax 770-488-2670, Email ljf5@cdc.gov - Brian Goodger, Contract Specialist, Phone 202-690-8011, Fax 202-690-7412, Email Brian.Goodger@hhs.gov